Glatopa (GLATIRAMER ACETATE)
Glatopa (GLATIRAMER ACETATE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Glatopa; Generic name: GLATIRAMER ACETATE; Manufacturer: Bryant Ranch Prepack.
| Brand name | Glatopa |
|---|---|
| Generic name | GLATIRAMER ACETATE |
| Manufacturer | Bryant Ranch Prepack |
| Used for | 1 INDICATIONS AND USAGE Glatopa is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatopa is indicated for the treatment of relapsing-forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION • For subcutaneous injection only; doses are not interchangeable ( 2.1 ) • Glatopa 20 mg/mL per day ( 2.1 ) • Glatopa 40 mg/mL three times per week ( 2.1 ) • Before use, allow the solution to warm to room temperature ( 2.2 ) 2.1 Recommended Dose Glatopa is for subcutaneous use only. Do not administer intravenously. The dosing schedule depends on the product strength that is selected. The recommended doses are: • Glatopa 20 mg per mL: administer once per day or • Glato |
| Active ingredient(s) | GLATIRAMER ACETATE |
| Route | SUBCUTANEOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=028fdf0e-2340-407b-bcd8-5a99accdddbf |